Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ABBOTT LABORATORIES Director's Dealing 2011

Apr 1, 2011

29777_dirs_2011-04-01_cd027877-cf37-4f9c-a5c7-f512ebf5d535.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2011-03-31

Reporting Person: Szela Mary T (Senior Vice President)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2011-03-31 Common shares without par value M 15960 $48.1225 Acquired 135302 Direct
2011-03-31 Common shares without par value S 13535 $49.25 Disposed 121767 Direct
2011-03-31 Common shares without par value S 2425 $49.26 Disposed 119342 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2011-03-31 Option (right to buy) $48.1225 M 15960 Disposed 2011-05-31 Common shares (15960) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common shares without par value 78 Indirect

Footnotes

F1: Balance in the Abbott Laboratories Stock Retirement Trust as of March 31, 2011.

F2: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3.